Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medication use and retinal vessel diameters.

Tien Yin Wong1, Michael D Knudtson, Barbara E K Klein

  • 1Centre for Eye Research Australia, University of Melbourne, East Melbourne 3002, Victoria, Australia. twong@unimelb.edu

American Journal of Ophthalmology
|March 1, 2005
PubMed
Summary

Topical beta-blocker eyedrops narrowed retinal vessels in a large study. Few other medications showed significant associations with retinal vessel diameters, indicating a specific effect of these glaucoma treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exome-Wide Analysis Identifies a Rare <i>EXD3</i> Missense Variant Associated With Diabetic Kidney Disease.

Kidney international reports·2026
Same author

Diabetes and incident stroke and mediation by microvascular dysfunction: Pooled analysis of three population-based studies.

Diabetes, obesity & metabolism·2025
Same author

Genetics of C-Peptide and Age at Diagnosis in Type 1 Diabetes.

Diabetes·2024
Same author

Association of macular pigment optical density with retinal layer thicknesses in eyes with and without manifest primary open-angle glaucoma.

BMJ open ophthalmology·2023
Same author

Association of fractal dimension and other retinal vascular network parameters with cognitive performance and neuroimaging biomarkers: The Multi-Ethnic Study of Atherosclerosis (MESA).

Alzheimer's & dementia : the journal of the Alzheimer's Association·2023
Same author

OMEGA-3 FATTY ACIDS ARE ASSOCIATED WITH DECREASED PRESENCE AND SEVERITY OF DIABETIC RETINOPATHY: A Combined Analysis of MESA and GOLDR Cohorts.

Retina (Philadelphia, Pa.)·2023

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Medical Research

Background:

  • Retinal vessel diameter is a key indicator of cardiovascular health.
  • Medication use can potentially influence vascular parameters.
  • Understanding medication effects on retinal vasculature is important for eye and systemic health.

Purpose of the Study:

  • To investigate the association between medication use and retinal vessel diameters.
  • To determine if specific drug classes impact arteriolar and venular size.

Main Methods:

  • Cross-sectional study analyzing retinal photographs from the Beaver Dam Eye Study (n=4926).
  • Retinal vessel diameters were measured from digitized images.
  • Medication use was recorded at the time of examination.

Related Experiment Videos

Main Results:

  • Topical beta-blocker eyedrops were associated with narrower retinal arteriolar (P=.05) and venular (P=.006) diameters.
  • Systemic beta-blocker use did not show a significant association with retinal vessel diameter.
  • Few other significant associations were found between medication use and retinal vessel dimensions.

Conclusions:

  • Medication use has limited impact on retinal vessel diameter.
  • Antiglaucoma medications, particularly topical beta-blockers, were linked to narrowed retinal vessels.
  • No association was found for systemic beta-blockers, suggesting a localized effect.